Malignant hyperthermia in myelomeningocele: a previously unreported association

Area of Science:

• Anesthesiology
• Pediatric Neurology
• Medical Genetics

Background:

• Malignant hyperthermia (MH) is a critical pharmacogenetic disorder triggered by volatile anesthetics and succinylcholine.
• Susceptibility to MH is inherited and associated with specific neuromuscular and orthopedic conditions.
• Previous literature has not established a link between MH susceptibility and myelomeningocele.

Observation:

• Three pediatric patients with myelomeningocele presented with symptoms suggestive of malignant hyperthermia susceptibility.
• These patients were seen within a Spina Bifida Clinic, highlighting a specific patient population.
• The clinical observations prompted a re-evaluation of potential associations with myelomeningocele.

Findings:

• The study identifies a potential association between myelomeningocele and malignant hyperthermia susceptibility.
• This observation challenges the existing understanding of conditions linked to MH.
• Further research is warranted to confirm this association and elucidate underlying mechanisms.

Implications:

• Clinicians should consider malignant hyperthermia susceptibility in pediatric patients with myelomeningocele presenting with relevant symptoms.
• This finding may necessitate revised anesthetic protocols for children with myelomeningocele.
• Expanding the list of associated conditions for MH susceptibility improves diagnostic awareness and patient safety.